Geneva Partners’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,405
Closed -$234K 71
2025
Q4
$234K Buy
+2,405
New +$228K 0.08% 69
2022
Q1
Sell
-2,679
Closed -$242K 100
2021
Q4
$242K Buy
+2,679
New +$232K 0.11% 89
2021
Q1
Sell
-4,725
Closed -$361K 92
2020
Q4
$361K Sell
4,725
-4,044
-46% -$298K 0.19% 83
2020
Q3
$630K Buy
8,769
+766
+10% +$54.9K 0.39% 52
2020
Q2
$550K Buy
+8,003
New +$540K 0.39% 54

Other funds holding IXJ

Geneva Partners's IXJ Position: Q1 2026 in Review

Geneva Partners sold out of iShares Global Healthcare ETF (IXJ) in Q1 2026, closing a stake of 2,405 shares — an estimated $234K sold.

Geneva Partners first reported a position in IXJ in Q2 2020 and held it in 5 quarters. The position peaked at $630K in Q3 2020. 285 funds tracked by Wall St. Rank hold IXJ as of Q1 2026.

  • Geneva Partners reported no remaining iShares Global Healthcare ETF position as of Q1 2026 after selling out during the quarter.
  • Geneva Partners sold 2,405 iShares Global Healthcare ETF shares in Q1 2026, an estimated $234K.
  • Geneva Partners first reported a position in iShares Global Healthcare ETF in Q2 2020 and held it in 5 quarters.
  • Geneva Partners's iShares Global Healthcare ETF position peaked at $630K in Q3 2020.
  • 285 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2026.

Based on Geneva Partners's 13F filing for Q1 2026, filed 29 Apr 2026.